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Abstract
Background: Danzhi Jiangtang Capsule (DJC), a Chinese medicinal formula, has been clinically used for treatment
of diabetes for many years. Previous studies have demonstrated that DJC was able to improve pancreatic islet
function in diabetes, but the underlying mechanisms remained unclear.
Methods: Streptozotocin (STZ) induced type 1 diabetic rats were treated with DJC for 6 weeks. Fasting plasma
insulin and fasting plasma glucose were determined at the end of experiment. Antioxidant status was evaluated by
measuring total antioxidant capacity, superoxide dismutase activity and malondialdehyde content in plasma and
pancreas. Paraffin sections of pancreas were subjected to H&E staining, TUNEL staining and immunohistochemical
examination. Protein levels of Bcl-2, Bax and pancreatic duodenal homeobox-1 (PDX-1) were measured by western
blot analysis. Activities of Caspase-3 and Caspase-9 were determined with commercially available kits.
Results: Supplementation with DJC resulted in a significant amelioration of type 1 diabetes as manifested by
reduced blood glucose, increased fasting plasma insulin and improved body weight gains. The atrophy and
reduction of pancreatic islets were also alleviated in DJC supplemented groups. DJC markedly reduced pancreatic
beta cell apoptosis, with Bax protein down-regulated and Bcl-2 protein up-regulated significantly. The activities of
caspase-3 and caspase-9 in pancreas were decreased evidently by DJC treatment. DJC effectively ameliorated
oxidative stress in type 1 diabetic rats, with the expression of PDX-1 protein increased markedly.
Conclusions: DJC was capable of attenuating STZ induced type 1 diabetes in rats, which might be attributed to
the suppression of pancreatic beta cell apoptosis. This study would provide further evidence for clinical use of
DJC in the management of diabetes.
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Background
Diabetes, a group of metabolic disease, is characterized by
chronic hyperglycemia due to defects in insulin secretion
and/or insulin action. Several lines of evidence indicated
that diverse risk factors for type 2 diabetes such as
overweight, physical inactivity and abdominal obesity can
induce insulin resistance, a condition in which the body
cells fail to respond effectively to insulin. In this situation,
pancreatic beta cells have to produce more insulin to over-
come this insensitivity, resulting in a state of hypergly-
cemia and hyperinsulinemia [1]. When pancreatic beta
cells fail to keep up with the increased needs for insulin,
excess glucose builds up in the bloodstream, leading
ultimately to type 2 diabetes and various complications.
Clinical data have demonstrated that, along with the
progression of diabetes, early stage hyperinsulinemia due
to insulin resistance transferred gradually to late stage
hypoinsulinemia secondary to progressive beta cell dam-
age, while blood glucose level remained high in the whole
process [2]. It is well established that hyperglycemia plays
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a critical role in the progressive damage of pancreatic beta
cells in diabetes [3], suggesting that protection of beta
cells from hyperglycemia induced damage might be an
effective approach to the management of diabetes.
Several lines of evidence indicated that chronic hyper-
glycemia could exacerbate pancreatic islet dysfunction
by inducing beta cell apoptosis or by decreasing the
activity of beta-cell specific transcription factors which
regulate insulin production, resulting in a decreased
beta cell mass and progressively impaired insulin
secretion [4, 5]. In vitro studies also indicated that
exposure to high level of glucose induced significant
beta cell apoptosis and impaired insulin secretion in
human islets and INS-1 cells [6, 7]. Data from clinical
studies demonstrated that diabetic patients had markedly
increased beta cell apoptosis and reduced beta-cell mass
[8]. Since compensatory islet formation and beta-cell pro-
liferation remained unchanged in diabetes, it is likely that
the main reason for the decrease in beta-cell mass is
increased cell apoptosis [9]. These findings suggest that
suppression of beta cell apoptosis might be a potential
therapeutic target for the treatment of diabetes.
Danzhi Jiangtang Capsule (DJC), a Chinese medicinal
formula consisting of cortex moutan (21.6 %), hetero-
phylly falsestarwort root (27.1 %), unprocessed rehmannia
root (21.6 %), oriental waterplantain rhizome (16.2 %),
dodder seed (10.8 %) and leech (2.7 %), possesses the
properties of supplementing Qi, nourishing Yin and
activating blood circulation. DJC is clinically used for
treatment of diabetes, which is called Xiaoke in traditional
Chinese medicine. Previous studies have shown that DJC
was able to lower blood glucose in patients with type 2
diabetes and experimental diabetic rats [10, 11]. It could
also improve pancreatic beta cell function in elderly dia-
betic patients [12]. However, the mechanisms underlying
these beneficial effects of DJC remained unclear. In the
present study, we investigated the effect of DJC on pancre-
atic beta cell apoptosis in STZ induced type 1 diabetic rats
and the possible mechanisms implicated.
Methods
Drug preparation
The six components of DJC were provided and identified
by The First Affiliated Hospital of Anhui University of
Chinese Medicine. All these herbs except leech were
extracted with boiled water for three times, followed by
concentration of the mixed extracts. After grinding into
fine powder, leech was mixed with the above mentioned
extracts. Then the mixture was dried, grinded and
capsulized for clinical use, with each capsule containing
0.4 g extract prepared from 8 g herbal medicine. For use
in this experiment, DJC powder was dissolved in distilled
water and given to rats intragastrically.
Animals and induction of diabetes
Sixty male Wistar rats aged 7 weeks (weight: 200–220 g)
were obtained from the Experimental Animal Center of
Nanjing Medical University and maintained in a
temperature and humidity controlled room with a 12 h
light–dark cycle. Rats were fed a standard diet with free
access to drinking water. After adaptive feeding for
1 week, all rats except 10 randomly allocated to Control
group were injected intraperitoneally with streptozotocin
(STZ, 50 mg/kg, Sigma, MO, USA) to induce type 1
diabetes. Ten days later, random blood glucose (RBG)
was determined, and rats with RBG levels ≥16.7 mmol/L
were defined as successful diabetic rats [13]. This study
was conducted in accordance with the Guide for the
Care and Use of Laboratory Animals and approved by
the Committee on the Care and Use of Laboratory
Animals of Anhui University of Chinese Medicine.
Animal grouping and drug dosing
Thirty-six diabetic rats were randomly allocated to 3
groups, namely diabetic group (Model), low dose of DJC
group (DJCL, 0.63 g/kg · d−1) and high dose of DJC
group (DJCH, 1.26 g/kg · d−1). The low dose of Danzhi
Jiangtang capsule was extrapolated from human dose
through normalization to body surface area (equivalent
dose). Rats in DJCH and DJCL groups were administered
intragastrically with DJC for 6 weeks, while those in
Control and Model groups were given distilled water of
the same volume. Doses of DJC were adjusted according
to the changes in body weight monitored biweekly. RBG
was measured biweekly by glucose oxidase method
using a commercial glucometer (Sinocare Incorporation,
Changsha China).
Biochemical analysis
At the end of the experiment, rats were fasted overnight
and anaesthetized by intraperitoneal injection of pento-
barbital sodium (40 mg/kg body weight). Blood samples
were collected into EDTA-coated tubes and plasma was
separated by centrifugation at 3000 g, 4 °C for 10 min
(Eppendorf Corporation, Hamburg, Germany). Fasting
plasma glucose (FPG) was determined by glucose
oxidase method (Nanjing Jiancheng Bioengineering
Company, Nanjing China) and fasting plasma insulin
(FINS) was measured by enzyme-linked immunosorbent
assay (Hufeng Biotech, Shanghai, China). Plasma levels
of Total antioxidant capacity (TAC) and superoxide dis-
mutase (SOD) activity were evaluated by ferric reducing
antioxidant power test and xanthine oxidase method,
respectively [14]. Malondialdehyde (MDA) content in
plasma was determined by thiobarbituric acid method
(Nanjing Jiancheng Bioengineering Company, Nanjing,
China). Pancreatic tissues were homogenized in phos-
phate buffered saline (PBS) and the levels of SOD
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activity and MDA content in the homogenates were de-
termined as described above. Activities of Caspase-3 and
Caspase-9 were determined with Colorimetric assay kit
(Beyotime institute of Biotechnology, Haimen, China).
Protein concentrations in pancreatic homogenates were
measured by Bradford’s method (Beyotime institute of
Biotechnology, Haimen, China). All biochemical analyses
were performed with a microplate reader (Thermo
Fisher Scientific Incorporation, MA, USA).
Histopathological examination
Tissues from the same region of pancreas were fixed in
formalin at room temperature overnight, followed by de-
hydration and embedding in paraffin. After deparaffinage
and rehydration, sections of 5 μm (Leica RM2245, Leica
Biosystems, Nussloch, Germany) were subjected to
hematoxylin and eosin (H&E) staining. Samples were ex-
amined under an Olympus IX51 microscope (Olympus
Corporation, Tokyo, Japan) by a pathologist.
Evaluation of pancreatic beta cell apoptosis
Pancreatic beta cell apoptosis was determined by terminal
deoxynucleotidyl transferase (TdT)-mediated dUTP nick
end labeling (TUNEL) assay. Paraffin sections (5 μm) were
incubated with proteinase K (20 μg/ml, Invitrogen, CA,
USA) at 37 °C for 20 min. Endogenous peroxidase activity
was blocked by incubation with 3 % hydrogen peroxide in
methanol. After rinsing with PBS, sections were subjected
to TUNEL staining according to the manufacturer’s
instructions (Roche Biochemicals, Mannheim, Germany).
The conjugated horseradish peroxidase was visualized
with diaminobenzidine (DAB, Sigma, MO, USA), followed
by counterstaining with hematoxylin. Six randomly
selected islets of each section were analyzed under high
magnification (×400) with Image-Pro Plus 6.0 (Media
Cybernetics MD, USA) for TUNEL-positive (apoptotic)
cells, with the results expressed as percentage of apoptotic
cells over total cells. The apoptotic rate of each animal
represents the mean of 6 randomly selected islets.
Immunohistochemical analysis
Paraffin sections were incubated with 3 % hydrogen
peroxide in methanol for 30 min to block endogenous
peroxidase activity. After antigen retrieval with micro-
wave heating and blocking with goat serum, sections
were incubated with monoclonal anti-body against Bax
and Bcl-2 (Santa Cruz, CA, USA) at 4 °C overnight.
Then the sections were incubated with biotinylated
secondary antibody (Zhongshan Golden Bridge., Beijing,
China) for 30 min, followed by incubation with horse-
radish peroxidase-conjugated streptavidin for 30 min at
room temperature. The peroxidase was visualized by
incubation with DAB solution in dark for 10 min and
then the sections were counterstained with hematoxylin.
Six randomly selected islets of each section were
captured under high magnification (×400) and analyzed
with Image-Pro Plus 6.0 for mean optical density [15].
The expression level of each animal represents the mean
of 6 randomly selected islets.
Western blot analysis
Pancreatic levels of Bcl-2, Bax and pancreatic duodenal
homeobox-1 (PDX-1) protein were evaluated by western
blot analysis. Total proteins were extracted with RIPA lysis
buffer (Beyotime institute of Biotechnology, Haimen,
China) supplemented with 1 mmol/L phenylmethanesul-
fonyl fluoride (PMSF, Sigma, MO, USA), followed by
determination of protein concentrations by bicinchoninic
acid (BCA) method (Beyotime institute of Biotechnology,
Haimen, China). Then protein samples were subjected to
SDS-polyacrylamide gel electrophoresis (Bio-Rad, CA,
USA) and transferred to nitrocellulose membrane
(Millipore, MA, USA). After blocking with 5 % skimmed
milk in TBS containing 0.2 % Tween-20 (TBST), the mem-
brane was incubated overnight at 4 °C with primary
antibodies against Bcl-2, Bax, PDX-1 (Santa Cruz, CA,
USA) and β-actin (Beyotime institute of Biotechnology,
Haimen, China), followed by incubation with horse-
radish peroxidase (HRP) conjugated secondary anti-
body (Beyotime institute of Biotechnology, Haimen,
Fig. 1 Effect of DJC on Blood Glucose a and Body Weight b in Rats. Data were presented as mean ± SD (n = 9 in Model group, n = 10 in the other
groups). **P < 0.01 vs Control group; #P < 0.05, ##P < 0.01 vs Model group
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China) for 1 h at room temperature. Bound HRP was
visualized with an enhanced chemiluminescence
substrate (ECL, Beyotime institute of Biotechnology,
Haimen, China) and protein bands were analyzed for
integrated optical density (IOD) with Quantity One
software (Bio-Rad, CA, USA). The levels of PDX-1,
Bcl-2 and Bax were normalized to that of β-actin.
Statistical analysis
Data were presented as mean ± SD. Comparisons among
groups were performed by one-way ANOVA followed by
the least significant difference (LSD) test. A value of
P < 0.05 was considered statistically significant. All
statistical analysis was performed with SPSS statistical




Thirty-six of 50 rats developed type 1 diabetes after
intraperitoneal injection of STZ as evidenced by
sustained hyperglycemia (≥16.7 mmol/L) 10 d after
STZ injection. During the whole experiment, three of
the 12 rats in Model group, two in DJCH group and
Fig. 2 Effect of DJC on fasting plasma insulin a and fasting plasma glucose b in rats. Fasting plasma insulin and fasting blood glucose were
determined by ELISA and glucose oxidase method, respectively. Data were presented as mean ± SD (n = 9 in Model group, n = 10 in the other
groups). **P < 0.01 vs Control group; #P < 0.05, ##P < 0.01 vs Model group
Fig. 3 Representative microphotographs of histopathological examination of pancreas (×400). Paraffin sections of pancreas (5 μm) were stained
with hematoxylin and eosin (H&E) and examined under a light microscope. a: Control group; b: Model group; c: DJCH group; d: DJCL group
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two in DJCL group died of diverse causes including
infection. As shown in Fig. 1, blood glucose in
diabetic rats remained high all through the experi-
ment (P < 0.01), while body weight gains were slowed
down significantly as compared to that in Control
group (P < 0.01). Supplementation with DJC resulted
in a marked reduction in blood glucose (P < 0.05 or
P < 0.01),and high dose of DJC significantly improved
body weight gains in diabetic rats (P < 0.05). These results
suggested that DJC was capable of ameliorating type 1
diabetes in rats.
Effect of DJC on fasting plasma insulin and fasting
plasma glucose
As shown in Fig. 2, FINS level in Model group was
markedly lower than that in Control group (P < 0.01),
while in DJC supplemented groups, levels of FINS were
increased evidently (P < 0.05 or P < 0.01). Consistently,
FPG in Model group was notably higher than that in
Control group (P < 0.01), whereas supplementation
with DJC resulted in a significant reduction in FPG
in type 1 diabetic rats (P < 0.05 or P < 0.01). Regres-
sion analysis revealed that FPG correlated negatively
with FINS (r = −0.576, P < 0.01). These results suggested
that the beneficial effect of DJC on type 1 diabetes
might be derived from the improvement of insulin
secretion capacity.
Effect of DJC on histopathological changes in pancreas
As shown in Fig. 3, pancreas from Control group had
quantitatively and morphologically normal islets,
which were encapsulated in fibrous membranes and
well demarcated from surrounding tissues. In model
group, however, notably reduced and atrophied islets
containing less beta cells were observed. In some
islets, beta cells developed degranulation and vacuolar
Fig. 4 Effect of DJC on pancreatic beta cell apoptosis in rats. Paraffin sections of pancreas (5 μm) were subjected to TUNEL staining examination
for beta cell apoptosis. Six randomly selected islets of each section were analyzed for apoptotic rate and averaged to serve as the apoptotic rate
of each animal. Data were presented as mean ± SD (n = 9 in Model group, n = 10 in the other groups). a-d: Representative microphotographs of
TUNEL staining (×400). a: Control group; b: Model group; c: DJCH group; d: DJCL group. e: Quantitative analysis of pancreatic islet cell apoptosis.
**P < 0.01 vs Control group; ##P < 0.01 vs Model group
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degeneration. As expected, treatment with DJC effectively
alleviated the histopathological changes mentioned
above, suggesting that the attenuation of type 1 dia-
betes by DJC might be derived from its protection of
pancreatic islets.
Effect of DJC on pancreatic beta cell apoptosis
Fig. 4 showed the results of TUNEL staining in pancreas.
TUNEL positive cells in pancreatic islets increased
notably in Model group (P < 0.01), while in DJC supple-
mented groups, TUNEL positive cells were reduced mark-
edly (P < 0.01). These results indicated that DJC was
capable of suppressing pancreatic beta cell apoptosis in
type 1 diabetes, which might be responsible for its benefi-
cial effect on diabetes.
Effect of DJC on Bax and Bcl-2 protein expression
As shown in Figs. 5 and 6, significantly increased levels of
Bax protein and decreased levels of Bcl-2 protein were ob-
served in pancreatic islets from Model group (P < 0.01),
while supplementation with DJC resulted in an evident
down-regulation of Bax protein and up-regulation of Bcl-2
protein (P < 0.01). A similar result was also observed by
Western blot analysis (Fig. 7). These findings were consist-
ent with the suppressive effect of DJC on beta cell apop-
tosis, suggesting that the anti-apoptotic effect of DJC
Fig. 5 Effect of DJC on Bax protein level in rat pancreas. Six randomly selected islets of each section were analyzed for mean optical density
and averaged to serve as the level of each animal. Data were presented as mean ± SD (n = 9 in Model group, n = 10 in the other groups).
a-d: Representative microphotographs of immunohistochemical examination of Bax protein (×400). a: Control group; b: Model group; c: DJCH
group; d: DJCL group. e: Quantitative analysis of Bax protein level. **P < 0.01 vs Control group; ##P < 0.01 vs Model group
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might be associated with its regulation of Bcl-2 family
protein expression.
Effect of DJC on the activities of Caspase-3 and Caspase-9
As shown in Fig. 8, the activities of Caspase-3 and
Caspase-9 in pancreas from Model group were signifi-
cantly higher than those from Control group (P < 0.01),
while in DJC supplemented groups, the activities of both
caspases were decreased evidently (P < 0.01). These results
indicated that inhibition of Caspase-3 and Caspase-9
activation might be a potential mechanism underlying the
anti-apoptotic effect of DJC in type 1 diabetic rats.
Effect of DJC on PDX-1 protein expression
As shown in Fig. 9, level of PDX-1 protein in pan-
creas from Model group was markedly lower than
that from Control group (P < 0.01), whereas in DJC
supplemented groups, PDX-1 protein levels were
increased markedly (P < 0.01).
Effect of DJC on antioxidant status in rats
As shown in Table 1, plasma levels of TAC and SOD
activity were significantly decreased in Model group
(P < 0.01), while MDA level was increased markedly
(P < 0.01). Consistently, a significantly decreased level
of SOD activity and increased content of MDA were
observed in pancreas from Model group (P < 0.01).
These results suggested that diabetic rats developed
significant oxidative stress. Supplementation with DJC
notably enhanced TAC and SOD activity in both
plasma and pancreatic tissues (P < 0.05 or P < 0.01),
with the levels of MDA decreased markedly (P < 0.05
or P < 0.01). These results indicated that DJC was able
Fig. 6 Effect of DJC on Bcl-2 protein level in rat pancreas. Six randomly selected islets of each section were analyzed for mean optical density
and averaged to serve as the expression level of each animal. Data were presented as mean ± SD (n = 9 in Model group, n = 10 in the other
groups). a-d: Representative microphotographs of immunohistochemical examination of Bcl-2 protein (×400). a: Control group; b: Model group;
c: DJCH group; d: DJCL group. e: Quantitative analysis of Bcl-2 protein level. **P < 0.01 vs Control group; ##P < 0.01 vs Model group
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to enhance antioxidant capacity and reduce oxidative
damage in type 1 diabetic rats.
Discussion
Increasing evidence indicated that chronic hyperglycemia
can not only cause damage to various organs of the body,
but also further exacerbate insulin deficiency by inducing
pancreatic beta cell apoptosis [16], forming a vicious cycle
leading to progressive deterioration of beta cell function
[17]. In the present study, intraperitoneal injection of STZ
induced severe hyperglycemia and reduced fasting plasma
insulin levels in rats, accompanied by a significantly
decrease in body weight gains. Consistently, histopatho-
logical examination showed that injection of STZ induced
significant atrophy and reduction of pancreatic islets.
These results suggested that rat model of type 1 diabetes
was established successfully. Supplementation with DJC
resulted in a marked increase of FINS and reduction of
blood glucose, with the general conditions including body
weight gains improved evidently. These results suggested
that DJC was capable of attenuating STZ-induced type 1
diabetes in rats and the beneficial effects might be derived
from protection of pancreatic islet function. This was in
accordance with a previous clinical observation [12], but
was inconsistent with another report that DJC decreased
FINS in diabetic patients [18]. This discrepancy might be
due to the reason that the patients recruited in the former
study were all aged people, which might be at a later stage
of diabetes with beta cell function seriously damaged.
These findings suggested that DJC might have a bidir-
ectional regulation effect on insulin secretion in dia-
betes, which was usually considered a main advantage
of Chinese herbal medicine.
A large amount of evidence indicated that chronic
hyperglycemia could induce oxidative stress and lead to
an increased accumulation of reactive oxygen species
(ROS), which can cause damage to various types of cells
[19]. Owing to relatively lower expression level of anti-
oxidant enzymes such as superoxide dismutase (SOD),
pancreatic beta cells are more susceptible to ROS induced
damage and apoptosis [20], which can lead to a progres-
sively impaired insulin secretion capacity. Excessive ROS
Fig. 7 Western blot analysis of pancreatic levels of Bax and Bcl-2.
Total protein were extracted from pancreas and subjected to western
blot analysis. Levels of Bax and Bcl-2 protein were normalized to that of
β-actin. Data were presented as percentage of that in Control group
(Mean ± SD, n= 5). **P< 0.01 vs Control group; ##P< 0.01 vs Model group
Fig. 8 Effect of DJC on the activities of Caspase-3 and Caspase-9.
The activities of caspase-3 and Caspase-9 in pancreas were determined
by using Caspase colorimetric assay Kit. Data were presented as
mean ± SD (n = 9 in Model group, n = 10 in the other groups).
**P < 0.01 vs Control group; ##P < 0.01 vs Model group
Fig. 9 Effect of DJC on PDX-1 protein expression. Total protein
extracted from pancreas were subjected to western blot analysis.
Levels of PDX-1 protein were normalized to that of β-actin. Data
were presented as percentage of that in Control group (Mean ± SD,
n = 5). **P < 0.01 vs Control group; ##P < 0.01 vs Model group
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can induce beta cell damage through interference
with intracellular signal transduction besides direct
oxidative injury [21]. Pancreatic and duodenal
homeobox-1 (PDX-1), a transcription factor expressed
mainly in pancreatic beta cells, plays a critical role in
pancreas development, beta cell maturation and sur-
vival, and the expression of a number of beta-cell
specific genes including insulin [22]. ROS can reduce
insulin synthesis and induce beta cell apoptosis
through down-regulation of PDX-1 protein expression
[23]. In the present study, diabetic rats developed
significant oxidative stress as manifested by decreased
levels of SOD activity and total antioxidant capacity
(TAC) and increased content of MDA, which are
usually used as biomakers of in vivo oxidative stress
[24]. In line with previous reports, expression of
PDX-1 protein was down-regulated significantly in
type 1 diabetic rats, accompanied by a significantly
decreased level of FINS and increased apoptotic rate
of pancreatic beta cells. By contrast, supplementation
with DJC resulted in a significant enhancement of
antioxidant capacity and decrease of MDA content in
diabetic rats, suggesting that DJC was able to amelior-
ate oxidative stress in type 1 diabetic rats. Consistent
with this result, supplementation with DJC led to an
evident up-regulation of PDX-1 protein, accompanied
by a marked reduction of pancreatic beta cell apop-
tosis. These results indicated that the beneficial effect
of DJC on diabetes might be derived from suppres-
sion of pancreatic beta cell apoptosis, which might be
related to its alleviation of oxidative stress and up-
regulation of PDX-1 protein expression.
In addition, immunohistochemical and western blot
analysis all demonstrated that supplementation with
DJC resulted in a significant up-regulation of Bcl-2
protein and down-regulation of Bax protein in pan-
creas. As a critical regulator of cell apoptosis, Bcl-2
family protein consists of both pro-apoptotic and
anti-apoptotic members [25]. Among these proteins,
Bax plays a pro-apoptotic role by inducing the release
of cytochrome C from mitochondria, leading to
caspase activation cascades and cell apoptosis. On the
contrary, Bcl-2 plays an anti-apoptotic role either by
sequestering pro-caspases or by preventing the release
of cytochrome C [26]. In consistence with the regulatory
effect of DJC on Bcl-2 related proteins, treatment with
DJC markedly decreased the activities of Caspase-3 and
Caspase-9. These results indicated that regulation of Bcl-2
family protein expression and subsequent inhibition of
Caspases activation might also play a role in the anti-
apoptotic effect of DJC in diabetes.
DJC consists of six Chinese herbs, most of which have
been demonstrated to possess antioxidant activity [27–29].
As a compound formula, DJC has been shown to increase
serum activities of SOD and GPx and decrease serum
content of MDA in patients with diabetes [30]. Our
previous studies also demonstrated that DJC was able
to increase the activities of SOD and GPx in pancre-
atic tissues from diabetic rats [31, 32]. The findings
of the present study were consistent with these re-
ports, indicating that DJC can increase antioxidant
capacity in diabetes through enhancement of antioxi-
dant enzymes activity. In addition, DJC has been
shown to decrease the expression of nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase
subunit p22phox in diabetic rats [31]. As a main
source of endogenous ROS in most mammalian cell
types, NADPH oxidase can be activated by hypergly-
cemia, resulting in an increased production of ROS
and oxidative damage. Previous studies have shown that
suppression of NADPH oxidase activity or protein
expression can markedly decrease hyperglycemia
induced ROS production in pancreatic beta cells and
improve insulin secretion function [33]. These find-
ings suggested that, besides enhancement of antioxi-
dant capacity, suppression of ROS production might
also contribute to the antioxidant capacity and benefi-
cial effect of DJC in diabetes.
Conclusions
In conclusion, this study demonstrated that DJC was
capable of attenuating STZ induced type 1 diabetes in
rats, which might be attributed, at least partly, to the
suppression of pancreatic beta cell apoptosis. These find-
ings were in accordance with clinical observations and
would provide further support for clinical use of DJC in
the management of diabetes.
Table 1 Effect of DJC on antioxidant status in type 1 diabetic rats
Groups Plasma TAC (U/mL) Plasma SOD (U/mL) Plasma MDA (nmol/mL) Pancreatic SOD (U/mgprot) Pancreatic MDA (nmol/mgprot)
Control 12.5 ± 1.8 241.4 ± 17.7 2.2 ± 0.4 10.4 ± 1.5 1.5 ± 0.3
Model 7.8 ± 1.2** 198.9 ± 21.8** 3.3 ± 0.5** 6.7 ± 1.3** 2.3 ± 0.4**
DJCH 10.6 ± 1.5## 230.7 ± 18.9## 2.3 ± 0.4## 9.2 ± 1.3## 1.7 ± 0.3##
DJCL 9.9 ± 1.5# 225.8 ± 14.5## 2.6 ± 0.4# 8.5 ± 1.6# 1.8 ± 0.3#
Data were presented as mean ± SD, n = 9 in Model group, n = 10 in the other groups)
**P < 0.01 vs Control group; #P < 0.05, ##P < 0.01 vs Model group
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